251 related articles for article (PubMed ID: 11254713)
1. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
González E; Punzón C; González M; Fresno M
J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
Maggirwar SB; Harhaj EW; Sun SC
Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
5. Identification of a CD28 response element in the CD40 ligand promoter.
Parra E; Mustelin T; Dohlsten M; Mercola D
J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
[TBL] [Abstract][Full Text] [Related]
6. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
[TBL] [Abstract][Full Text] [Related]
7. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.
Butscher WG; Powers C; Olive M; Vinson C; Gardner K
J Biol Chem; 1998 Jan; 273(1):552-60. PubMed ID: 9417115
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional block in the IL-2 promoter at the -150 AP-1 site in effector CD8+ T cells.
Finch RJ; Fields PE; Greenberg PD
J Immunol; 2001 Jun; 166(11):6530-6. PubMed ID: 11359804
[TBL] [Abstract][Full Text] [Related]
9. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.
Kempiak SJ; Hiura TS; Nel AE
J Immunol; 1999 Mar; 162(6):3176-87. PubMed ID: 10092768
[TBL] [Abstract][Full Text] [Related]
10. c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.
Shapiro VS; Mollenauer MN; Greene WC; Weiss A
J Exp Med; 1996 Nov; 184(5):1663-9. PubMed ID: 8920856
[TBL] [Abstract][Full Text] [Related]
11. Functional disparity of distinct CD28 response elements toward mitogenic responses.
Civil A; Rensink I; Aarden LA; Verweij CL
J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
[TBL] [Abstract][Full Text] [Related]
12. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
13. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
Shapiro VS; Truitt KE; Imboden JB; Weiss A
Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
[TBL] [Abstract][Full Text] [Related]
14. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.
Ott M; Lovett JL; Mueller L; Verdin E
J Immunol; 1998 Mar; 160(6):2872-80. PubMed ID: 9510190
[TBL] [Abstract][Full Text] [Related]
15. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
16. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
[TBL] [Abstract][Full Text] [Related]
17. Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.
Iacobelli M; Wachsman W; McGuire KL
J Immunol; 2000 Jul; 165(2):860-8. PubMed ID: 10878360
[TBL] [Abstract][Full Text] [Related]
18. The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat.
Ehret A; Li-Weber M; Frank R; Krammer PH
Eur J Immunol; 2001 Jun; 31(6):1790-9. PubMed ID: 11385624
[TBL] [Abstract][Full Text] [Related]
19. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
20. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
